1. Home
  2. BZUN vs OBIO Comparison

BZUN vs OBIO Comparison

Compare BZUN & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZUN
  • OBIO
  • Stock Information
  • Founded
  • BZUN 2007
  • OBIO 2017
  • Country
  • BZUN China
  • OBIO United States
  • Employees
  • BZUN N/A
  • OBIO N/A
  • Industry
  • BZUN Catalog/Specialty Distribution
  • OBIO Medicinal Chemicals and Botanical Products
  • Sector
  • BZUN Consumer Discretionary
  • OBIO Health Care
  • Exchange
  • BZUN Nasdaq
  • OBIO Nasdaq
  • Market Cap
  • BZUN 144.4M
  • OBIO 118.8M
  • IPO Year
  • BZUN N/A
  • OBIO N/A
  • Fundamental
  • Price
  • BZUN $2.65
  • OBIO $2.71
  • Analyst Decision
  • BZUN Buy
  • OBIO Strong Buy
  • Analyst Count
  • BZUN 2
  • OBIO 4
  • Target Price
  • BZUN $3.20
  • OBIO $14.00
  • AVG Volume (30 Days)
  • BZUN 324.9K
  • OBIO 322.2K
  • Earning Date
  • BZUN 08-27-2025
  • OBIO 08-19-2025
  • Dividend Yield
  • BZUN N/A
  • OBIO N/A
  • EPS Growth
  • BZUN N/A
  • OBIO N/A
  • EPS
  • BZUN N/A
  • OBIO N/A
  • Revenue
  • BZUN $1,310,110,798.00
  • OBIO $2,886,000.00
  • Revenue This Year
  • BZUN $5.27
  • OBIO $20.47
  • Revenue Next Year
  • BZUN $3.46
  • OBIO $11.45
  • P/E Ratio
  • BZUN N/A
  • OBIO N/A
  • Revenue Growth
  • BZUN 6.77
  • OBIO 30.23
  • 52 Week Low
  • BZUN $2.12
  • OBIO $2.37
  • 52 Week High
  • BZUN $4.38
  • OBIO $7.04
  • Technical
  • Relative Strength Index (RSI)
  • BZUN 42.54
  • OBIO 42.41
  • Support Level
  • BZUN $2.58
  • OBIO $2.55
  • Resistance Level
  • BZUN $2.77
  • OBIO $2.76
  • Average True Range (ATR)
  • BZUN 0.13
  • OBIO 0.19
  • MACD
  • BZUN -0.02
  • OBIO -0.06
  • Stochastic Oscillator
  • BZUN 14.00
  • OBIO 24.77

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: